Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Successful trabeculotomy in a patient with corticosteroid-induced glaucoma with anti-aquaporin 4 antibody-positive neuromyelitis optica: a case report.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
Diffusion tensor magnetic resonance imaging may show abnormalities in the normal-appearing cervical spinal cord from patients with multiple sclerosis.
[Resources and Self-Management Skills in Multiple Sclerosis Patients - Can the Scale Structure of the Questionnaire FERUS be Replicated?]
Dermatoglyphic features in patients with multiple sclerosis.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Linking synaptopathy and gray matter damage in multiple sclerosis.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Cardiovascular effects of fingolimod: A review article.
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Lysophospholipids and their receptors in the central nervous system.
Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity.
The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis.
Involvement of MicroRNA in Microglia-Mediated Immune Response.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Contrast sensitivity in relapsing-remitting multiple sclerosis assessed by sine-wave gratings and angular frequency stimuli.
[A review of multiple sclerosis (1). Presentation of a case.]
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].

Pages